FDA Inspection 1120998 — Hetero Labs Ltd
The FDA completed an inspection of Hetero Labs Ltd on February 14, 2020 in Sanath Nagar. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Sanath Nagar (India)
Additional Details
Postmarket Adverse Drug Experience (PADE)